Moody's assigns 'A1' rating to Aspirus' bonds

Moody's Investors Service assigned its "A1" rating to Wausau, Wis.-based Apirus' proposed $68 million series 2017 revenue bonds.

In addition, Moody's affirmed the "A1" rating on Aspirus' series 2015A, series 2013, series 2004 and series 1998B bonds, affecting a total of $164 million of debt.

The assignment and affirmation are a result of several factors, including Aspirus' solid operating performance, favorable balance sheet metrics and modest leverage. Moody's also acknowledged Apirus' highly competitive market, small size and upcoming capital spending.

The outlook is stable, reflecting Moody's expectation that Aspirus will maintain its operating performance and favorable liquidity metrics through the upcoming period of high capital spending.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars